Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
013/017 - Behandlung <strong>der</strong> Akne aktueller Stand: 02/2010<br />
korrigierte Fassung: 10/2011<br />
163. Fanta D, Scholz N. [Miconazole-benzoyl peroxide: a new combination for extending<br />
the topical therapy of acne]. Z Hautkr. 1984; 59: 873-81.<br />
164. Reinel D, Beierdorffer H. [A new drug combination for the topical treatment of acne.<br />
Miconazole 2% + benzoyl peroxide 5% versus benzoyl peroxide 5%--a double-blind<br />
study]. Z Hautkr. 1985; 60: 648-50, 53-6.<br />
165. Beer P. Untersuchungen über die Wirkung <strong>der</strong> Vitamin-A-Säure. Dermatologica.<br />
1962; 124: 192-5.<br />
166. Stüttgen G. Zur Lokalbehandlung von Keratosen mit Vitamin A-Säure.<br />
Dermatologica. 1962; 124.<br />
167. Krishnan G. Comparison of two concentrations of tretinoin solution in the topical<br />
treatment of acne vulgaris. Practitioner. 1976; 216: 106-9.<br />
168. Christiansen J, Holm P, Reymann F. The retinoic acid <strong>der</strong>ivative Ro 11-1430 in Acne<br />
vulgaris. A controlled multicenter trial against retinoic acid. Dermatologica. 1977;<br />
154: 219-27.<br />
169. Webster GF. Safety and efficacy of Tretin-X compared with Retin-A in patients with<br />
mild-to-severe acne vulgaris. Skinmed. 2006; 5: 114-8.<br />
170. Lavker RM, Leyden JJ, Thorne EG. An ultrastructural study of the effects of topical<br />
tretinoin on microcomedones. Clin Ther. 1992; 14: 773-80.<br />
171. Berger R, Barba A, Fleischer A, Leyden JJ, Lucky A, Pariser D, Rafal E, Thiboutot D,<br />
Wilson D, Grossman R, Nighland M. A double-blinded, randomized, vehiclecontrolled,<br />
multicenter, parallel-group study to assess the safety and efficacy of<br />
tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults. Cutis.<br />
2007; 80: 152-7.<br />
172. Lucky AW, Cullen SI, Jarratt MT, Quigley JW. Comparative efficacy and safety of<br />
two 0.025% tretinoin gels: results from a multicenter double-blind, parallel study. J<br />
Am Acad Dermatol. 1998; 38: S17-23.<br />
173. Mills OH, Jr., Kligman AM. Treatment of acne vulgaris with topically applied<br />
erythromycin and tretinoin. Acta Derm Venereol. 1978; 58: 555-7.<br />
174. Kreusch J, Bextermoller R. Efficacy and tolerability of a topical<br />
erythromycin/tretinoin combination preparation in acne treatment: post-marketing<br />
surveillance study involving over 6500 patients. Curr Med Res Opin. 2000; 16: 1-7.<br />
175. Korting HC, Braun-Falco O. Efficacy and tolerability of combined topical treatment<br />
of acne vulgaris with tretinoin and erythromycin in general practice. Drugs Exp Clin<br />
Res. 1989; 15: 447-51.<br />
176. Gupta AK, Lynde CW, Kunynetz RA, Amin S, Choi K, Goldstein E. A randomized,<br />
double-blind, multicenter, parallel group study to compare relative efficacies of the<br />
topical gels 3% erythromycin/5% benzoyl peroxide and 0.025%<br />
tretinoin/erythromycin 4% in the treatment of mo<strong>der</strong>ate acne vulgaris of the face. J<br />
Cutan Med Surg. 2003; 7: 31-7.<br />
177. Handojo I. Retinoic acid cream (Airol cream) and benzoyl-peroxide in the treatment<br />
of acne vulgaris. Southeast Asian J Trop Med Public Health. 1979; 10: 548-51.<br />
178. Richter JR, Forstrom LR, Kiistala UO, Jung EG. Efficacy of the fixed 1.2%<br />
clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary<br />
0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne. J Eur<br />
Acad Dermatol Venereol. 1998; 11: 227-33.<br />
Seite 116 von 136
Change language